Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

February 9, 2010

Oral drugs to treat multiple sclerosis could become available in 2011

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Information provided by Odalys in Miami: with regards to Oral Cladribine and Fingolimod Oral drugs to treat multiple sclerosis could…
MS Drug Therapies

February 8, 2010

New Study Finds Specialized Support Programs Can Increase Treatment Adherence and Persistence, Reduce Relapses for People with Multiple Sclerosis

  • MS Research Study and Reports
    /
Study Patients Also Reported Improved Ability to Manage Their Health Support Programs May Yield Cost Savings Press Release Source: UnitedHealth…
MS Research Study and Reports

February 8, 2010

Multiple Sclerosis: Blacks Have More Severe Symptoms, Decline Faster Than Whites, New Study Shows

  • Multiple Sclerosis
    /
February 8, 2010 Fewer African Americans than Caucasians develop multiple sclerosis (MS), statistics show, but their disease progresses more rapidly,…
Multiple Sclerosis

February 8, 2010

Research on the Blood-Brain Barrier in MS

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
  • Myelin Repair
    /
What is the blood-brain-barrier? The blood-brain barrier (BBB) is a specialized structure formed by the blood vessels of the central…
Additional MS resource sites

February 6, 2010

Biogen Plans First Study For Earlier Use Of MS Drug Tysabri

  • Multiple Sclerosis
    /
  • Tysabri
    /
By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones) Biogen Idec Inc. (BIIB) is planning the first clinical…
Multiple Sclerosis

February 5, 2010

AMPYRA for Multiple Sclerosis – Pricing that will benefit the MS Patient

  • Additional MS resource sites
    /
  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • MS Drug Therapies
    /
  • Symptoms
    /
Information found here was provided by Acorda Therapeutics February 5, 2010 The wholesale acquisition cost is $1,065 per 30-day supply…
Additional MS resource sites

February 5, 2010

FDA warns of brain risks with frequent Tysabri use

  • Multiple Sclerosis
    /
  • Tysabri
    /
Yahoo Finance FDA finds connection between brain inflammation and frequent use of Tysabri On Friday February 5, 2010, 12:53 pm…
Multiple Sclerosis

February 5, 2010

New Multiple Sclerosis treatment may end with Utah woman

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
I ask “WHY” stop? – Read the article and you will understand my question. Reported by: Barbara SmithLast Update: 2/04…
MS Drug Therapies

February 5, 2010

Multiple Sclerosis Gait issues – a two-part webinar

  • Multiple Sclerosis
    /
  • National MS Society Related
    /
  • Symptoms
    /
MS Learn Online Presents: Gait and MS: A Common Issue A two-part video webcast series that explores: Symptoms that contribute…
Multiple Sclerosis

February 4, 2010

Oral Cladribine for Relapsing Multiple Sclerosis – Info on a Placebo-Controlled Study

  • MS Research Study and Reports
    /
Background Cladribine provides immunomodulation through selective targeting of lymphocyte subtypes. We report the results of a 96-week phase 3 trial…
MS Research Study and Reports

Categories

Latest Blog Posts